Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 26, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
62037-726-01
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)
Initial Posting
Jul 26, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.